cosmin4000/iStock via Getty Images
Omeros Corporation (NASDAQ:OMER) said on Tuesday that the U.S. FDA has accepted the resubmitted label expansion application for narsoplimab, a treatment for transplant-associated thrombotic microangiopathy, which can occur after stem cell transplants. The biologics license application resubmission is classified as
Wright National Flood Insurance Company (Wright Flood), through its affiliate Wright National Flood Insurance Services, is set to acquire the...
Oct. 27, 2025 5:38 AM ETiShares China Large-Cap ETF (FXI), YINN, YANG, MCHI, ASHR, PGJ, BDNCE Stock, REMX, SOYB, SETMBy:...
After a brief bout of profit booking, the bulls seem to have regained control of Dalal Street, with both Nifty...
Barclays Plc is returning to Saudi Arabia after an 11-year absence, marking both a strategic expansion for the British lender...
Shares of mid-tier IT services company Coforge rallied 6% to their day's high of Rs 1,867 on Monday, October 27,...
President Javier Milei’s party is on track to finish first in Argentina’s midterm vote in early counting, putting the libertarian...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.
